Admission Date:  [**2188-3-30**]              Discharge Date:   [**2188-4-12**]  Date of Birth:  [**2124-9-8**]             Sex:   F  Service: MEDICINE  Allergies: Naprosyn / Oak  Attending:[**First Name3 (LF) 783**] Chief Complaint: SOB and hypoxia  Major Surgical or Invasive Procedure: VATS  History of Present Illness: Please see MICU admission note for full details of initial presentation.
She presented to OSH, received steroids and was transferred to [**Hospital1 18**] for rule out PE.
In MICU, she was started empirically of levaquin for dry cough, diuresed to lasix (20mg IV X2) with total LOS negative 1.9L and oxygenation improved to 94-95% 4LNC.
She reports being treated with 60 mg prednisone for at least 2 months.
No known asbestos exposure Smoking: quit in [**2150**] EtOH: none  Family History: Father: asthma Mother with severe RA Sisters with COPD  Physical Exam: Admission PE: 97.2 153/68 89 93%4LNC O2 Sats Gen: pleasant, obese, speaking comfortably HEENT: Clear OP, MMM NECK: Supple, No LAD, No JVD CV: RR, NL rate.
A right internal jugular catheter terminates in the lower SVC.
Pulmonary Report SPIROMETRY, LUNG VOLUMES, DLCO Study Date of [**2188-4-3**]  10:23 AM SPIROMETRY 10:23 AM Pre drug Post drug        Actual Pred  %Pred   Actual  %Pred %chg FVC      2.16 3.23   67     2.35     73     +9 FEV1     1.24 2.36   52     1.38     59     +12 MMF      0.47 2.62   18     0.60     23     +27 FEV1/FVC57 73   78   59     81              +3  LUNG VOLUMES 10:23 AM Pre drug Post drug     Actual    Pred    %Pred TLC   5.34    5.26     102 FRC   3.03    3.01     101 RV   2.77    2.03      136 VC   2.57    3.23       80 IC   2.31    2.25      103 ERV  0.26    0.98       27 RV/TLC 52      39      134 He Mix Time   4.25  DLCO 10:23 AM       Actual    Pred   %Pred DSB    14.23    19.09   75 VA(sb)  4.26    5.26    81 HB      3.70 DSB(HB)14.10    19.09   74 DL/VA   3.31     3.63   91 .
She was initially requiring an NRB and was admitted to the ICU overnight.
She received albuterol and ipratropium nebs q6hours; no steroids or Advair.
She was switched from Tiotropium and Advair to Combivent 4 times daily as her symptoms and oxygenation appeared to improve with frequent nebs.
Beta-blocker was stopped to avoid bronchospasm.
Her work up included: ANCA- negative; [**Doctor First Name **] 1:40 (negative); Galactomanin and B-glucan negative; IgE <2.0; absolute peripheral eosinophilia of 300; Hypersensitvity panel negative.
She was stared on Prednisone 40mg daily.
She was started on bisphosphate and calcium w/ vit D. She was also started on bactrim for PCP [**Name Initial (PRE) 1102**].
# Purulent discharge from port-a-cath: On [**2188-4-6**], the lumen of the patient's port-a-cath was found to be draining discharge.
As the patient had not used the port-a-cath for treatment in 6+ months, the port-a-cath was removed at the same time as the VATS.
She had no secondary indication for an ACE-i.
The acute renal failure may have been due either to IV contrast or diuresis on admission.
No further diuresis was performed and her ins/out kept even.
Medications on Admission: MEDS on TRANSFER: Levofloxacin 750 mg IV QDAILY Albuterol-Ipratropium [**11-21**] PUFF IH Q6H:PRN Fexofenadine 60 mg PO BID Fluticasone-Salmeterol (250/50) 1 INH IH [**Hospital1 **] Tiotropium Bromide 1 CAP IH DAILY Levothyroxine Sodium 100 mcg PO DAILY Metoprolol Tartrate 25 mg PO BID Tricor *NF* 145 mg Oral daily Acetaminophen 325-650 mg PO Q6H:PRN Celebrex *NF* 200 mg Oral daily Duloxetine 60 mg PO DAILY Pantoprazole 40 mg PO Q24H Colace/Senna .
HOME MEDS: fexofenadine celebrex 200mg po daily nexium 40mg po dialy fluticasone/salmeterol 500/50 tiotropium cymbalta 60mg po daily combivent tricor 145 metoprolol 25mg po bid synthroid 100mcg po daily .
Fexofenadine 60 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Celecoxib 200 mg Capsule Sig: One (1) Capsule PO daily ().
Nexium 40 mg Capsule, Delayed Release(E.C.)
Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Fenofibrate Micronized 145 mg Tablet Sig: One (1) Tablet PO daily ().
Duloxetine 30 mg Capsule, Delayed Release(E.C.)
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for pain.
Combivent 18-103 mcg/Actuation Aerosol Sig: Two (2) puffs Inhalation four times a day.
Hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO DAILY (Daily).
Lorazepam 0.5 mg Tablet Sig: 1-2 Tablets PO Q8H (every 8 hours) as needed for anxiety.
Bacitracin Zinc 500 unit/g Ointment Sig: as directed Appl Topical [**Hospital1 **] (2 times a day) for 4 days: apply a small amount to Vats incisions.
Prednisone 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Trimethoprim-Sulfamethoxazole 80-400 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Dextromethorphan-Guaifenesin 10-100 mg/5 mL Liquid Sig: Five (5) ML PO Q6 () as needed for cough for 10 days.
Morphine 15 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for pain for 2 weeks.
Fosamax 5 mg Tablet Sig: One (1) Tablet PO once a day: Take with a full glass of water in the morning.
Discharge Diagnosis: Sarcoid   Discharge Condition: stable, continues to require 2-3L NC to maintain SaO2 >92%   Discharge Instructions: You were admitted with shortness of breath and hypoxia.
You received a VATS and were diagnosed with Sarcoid.
In addition, you should take bactrim to prevent PCP.
[**Name10 (NameIs) **] is also important that you take calcium and vit D to prevent decreased bone density on prednisone.
Start taking Prednisone 2.
Start taking Bactrim 3.
Start taking Calcium with Vit D for bone strength.
Start taking Fosamax to prevent osteoporosis while being on prednisone.
Start taking Dextromethorphan with Guiafenisin (cough supressant) as needed for cough.
Stop taking Metoprolol 8.
Take Combivent 4 times a day instead.
Take tylenol for mild pain.
Take Morphine IR for severe pain.
You can put a small amount of bacitracin on your VATS inscisions for a few days while they are healing.
You should have a dexa-scan to look at your bone density.
You should also have your vitamin D and calcium levels monitored as you have been started on a Bisphosphonate to prevent osteoporosis.
